Androgen receptor (AR) directly regulates miR-21 by binding to the miR-21 promoter in prostate cancer [102]; Siddiqui and coworkers (2011) demonstrated that EGCG inhibited prostate cancer cell growth by decreasing the level of AR and miR-21 [63]. This evidence concerns the gene AR and prostate carcinoma.